Plus Therapeutics, Inc.
PSTV
$0.26
$0.00-1.69%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.71M | -4.42M | 5.15M | -17.40M | -3.90M |
| Total Depreciation and Amortization | 145.00K | 77.00K | 77.00K | 146.00K | 348.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -20.00K |
| Total Other Non-Cash Items | 670.00K | 539.00K | -6.52M | 12.52M | -9.00K |
| Change in Net Operating Assets | -1.36M | 1.26M | -4.50M | -1.44M | 2.37M |
| Cash from Operations | -6.26M | -2.55M | -5.80M | -6.17M | -1.21M |
| Capital Expenditure | -30.00K | -27.00K | -7.00K | -3.00K | -11.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 30.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.05M | 1.32M | -4.63M | 3.53M | 75.00K |
| Cash from Investing | -1.08M | 1.30M | -4.63M | 3.56M | 64.00K |
| Total Debt Issued | 750.00K | 0.00 | 0.00 | 3.74M | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -7.00M | 0.00 |
| Issuance of Common Stock | 3.00M | 16.86M | 3.02M | 15.66M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -949.00K | -4.55M | -220.00K | -- | -- |
| Cash from Financing | 2.80M | 12.31M | 2.80M | 12.41M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.53M | 11.06M | -7.63M | 9.79M | -1.15M |